Fintel reports that on January 23, 2025, Jefferies downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 21.99% Upside As of December 23, 2024, ...